UPDATE 2-Nektar withdraws application for opioid painkiller after FDA panel's vote

Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration (FDA) panel unanimously voted against the drug's approval.